Trump Nominates Pro-Life Doctor to be Next FDA Chief

The nomination comes as the FDA is currently conducting a much-anticipated safety review of the abortion drug mifepristone.

Massachusetts Legalizes Abortion Up to Birth

The bill puts Massachusetts on par with Oregon and countries like North Korea and China that also allow unlimited legal abortion.

Federal Funding to Planned Parenthood Resumes As Pro-Life Leaders Continue Urging Congress to Act

Pro-life leaders are calling on Congress to use the means still at their disposal to implement a permanent freeze.

Pro-Life Leaders Urge Congress to Renew Defunding of Planned Parenthood Before July 4

The abortion business is set to regain federal funding on July 4, 2026, unless Congress acts to extend the defunding by another year or permanently block Planned Parenthood from receiving Medicaid dollars.

Report: FDA’s Mifepristone Safety Review Could Be Completed by September

The news comes after the agency earlier this month confirmed that its review was moving into a new data analysis phase.

Tagged abortion drugsabortion pillschemical abortionFDAHHS Kyle Diamantasmifepristonemifepristone reviewmisoprostolTrump administrationU.S. Department of Health and Human ServicesU.S. Food and Drug Administration